Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Eremid Research Services has been established as the new name for the commercial arm of the 501(c)(3) non-profit, research organization - DHMRI.
read more
Monday, December 21, 2020
Ergomed has announced the acquisition of MS Clinical Services, a specialized CRO based in Houston, Texas.
read more
ERS Genomics Limited announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.
read more
CRISPR offerings to enhance NUVISAN’s drug development service portfolio.
read more
ERS Genomics has announced the signing of a license agreement with Otsuka Pharmaceutical.
read more
Monday, September 21, 2020
ERS Genomics has signed an agreement with Applied StemCell, a provider of stem cell, animal model, antibody discovery services and reagents.
read more
ERS Genomics announced the signing of a license agreement granting Axxam access to ERS Genomics' CRISPR-Cas9 patent portfolio, to support Axxam's integrated discovery service platform.
read more
Friday, November 10, 2017
ERS Genomics and Cellecta announced a non-exclusive license agreement to provide Cellecta worldwide access to ERS Genomics' CRISPR/Cas9 genome editing intellectual.
read more
Thursday, February 25, 2021
ERS Genomics has announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Thursday, February 18, 2021
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
ERT has announced the acquisition of APDM Wearable Technologies, a next-generation provider of wearables and digital biomarkers.
read more
Monday, September 11, 2017
ERT announced it has acquired Biomedical Systems, a well-recognized provider of reliable imaging, as well as cardiac safety and respiratory data collection solutions.
read more
Monday, December 19, 2016
ERT, a l provider of high-quality patient data collection solutions for use in clinical drug development, has announced the acquisition of Exco InTouch, a provider of patient engagement, data capture and digital health solutions. The combined ...
read more
Monday, December 04, 2017
ERT has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory solutions that accelerate clinical research.
read more
ERT announced the acquisition of ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center.
read more